Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease-Reference-Cited by-同舟云学术

Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease

Published:2022-02-23 Issue:9 Volume:56 Page:5727-5757
ISSN:0953-816X
Container-title:European Journal of Neuroscience
language:en
Short-container-title:Eur J of Neuroscience

Author:

Cummings Jeffrey¹^ORCID,Ortiz Andrew²^ORCID,Castellino Janelle³,Kinney Jefferson¹²

Affiliation:

1. Chambers‐Grundy Center for Transformative Neuroscience, Department of Brain Health, School of Integrated Health Sciences University of Nevada Las Vegas (UNLV) Las Vegas Nevada USA

2. Department of Brain Health, School of Integrated Health Sciences University of Nevada Las Vegas (UNLV) Las Vegas Nevada USA

3. School of Medicine University of Nevada Las Vegas Las Vegas Nevada USA

Funder

National Institute of Neurological Disorders and Stroke

National Institutes of Health

Alzheimer's Drug Discovery Foundation

National Institute on Aging

National Institute of General Medical Sciences

Publisher

Wiley

Subject

General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejn.15619

Reference256 articles.

1. The Insulin Receptor Tyrosine Kinase Substrate p58/53 and the Insulin Receptor Are Components of CNS Synapses

2. Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition

3. Insulin improves memory and reduces chronic neuroinflammation in the hippocampus of young but not aged brains

4. Genetic origin of a large family with a novel PSEN1 mutation (Ile416Thr)

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier;Ageing Research Reviews;2024-11

2. Diabetes and brain disorders, a new role for insulin?;Neuroscience & Biobehavioral Reviews;2024-08

3. Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of Neurodegeneration;Biomolecules;2024-07-19

4. Hypoglycemic TCM formulas (Huangqi-Gegen drug pair) have the potential as an Alzheimer's disease;Phytomedicine;2024-07

5. A Systematic Review of Semaglutide’s Influence on Cognitive Function in Preclinical Animal Models and Cell-Line Studies;International Journal of Molecular Sciences;2024-05-02